Clear Liquid Diets and Enhanced Safety in Procedures: Insights from the OCULUS Trial—A Response
-
By
-
Akram I. Ahmad
-
Tilak Shah
-
September 1, 2026
Original Source(s)
Clear Liquids, Safer Procedures—Lessons from the OCULUS Trial—Reply
-
by Akram I. Ahmad, Tilak Shah
September 1, 2026
Related Content
Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma
by Sima Ardalan Khales, Sina Mozaffari‑Jovin, Dirk Geerts, Mohammad Reza Abbaszadegan
September 11, 2026
